6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Shifts in the fecal microbiota associated with adenomatous polyps

      research-article
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Adenomatous polyps are the most common precursor to colorectal cancer (CRC), the second leading cause of cancer death in the United States. We sought to learn more about early events of carcinogenesis by investigating shifts in the gut microbiota of patients with adenomas.

          Methods

          We analyzed 16S rRNA gene sequences from the fecal microbiota of patients with adenomas (n=233) and without (n=547).

          Results

          Multiple taxa were significantly more abundant in patients with adenomas, including Bilophila, Desulfovibrio, pro-inflammatory bacteria in the genus Mogibacterium, and multiple Bacteroidetes species. Patients without adenomas had greater abundances of Veillonella, Firmicutes (Order Clostridia), and Actinobacteria (family Bifidobacteriales). Our findings were consistent with previously reported shifts in the gut microbiota of CRC patients. Importantly, the altered adenoma profile is predicted to increase primary and secondary bile acid production, as well as starch, sucrose, lipid, and phenylpropanoid metabolism.

          Conclusions

          These data hint that increased sugar, protein, and lipid metabolism along with increased bile acid production could promote a colonic environment that supports the growth of bile-tolerant microbes such as Bilophilia and Desulfovibrio. In turn, these microbes may produce genotoxic or inflammatory metabolites such as H 2S and secondary bile acids, which could play a role in catalyzing adenoma development and eventually CRC.

          Impact

          This study suggests a plausible biological mechanism to explain the links between shifts in the microbiota and CRC. This represents a first step toward resolving the complex interactions that shape the adenoma-carcinoma sequence of CRC and may facilitate personalized therapeutics focused on the microbiota.

          Related collections

          Author and article information

          Journal
          9200608
          2299
          Cancer Epidemiol Biomarkers Prev
          Cancer Epidemiol. Biomarkers Prev.
          Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
          1055-9965
          1538-7755
          22 September 2016
          26 September 2016
          January 2017
          01 January 2018
          : 26
          : 1
          : 85-94
          Affiliations
          [1 ]Department of Surgery, Mayo Clinic, Rochester, MN, USA
          [2 ]Microbiome Program, Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA
          [3 ]Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA
          [4 ]Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA
          [5 ]Division of Anatomic Pathology, Mayo Clinic, Rochester Minnesota, USA
          [6 ]Division of Gastroenterology, Kaiser Permanente, Oakland, CA, USA
          [7 ]Division of Gastroenterology, Indiana University School of Medicine, Indianapolis, IN, USA
          [8 ]Denver Department of Veterans Affairs Medical Center, University of Colorado Denver School of Medicine, Denver, CO, USA
          [9 ]University of Arizona Cancer Center, Tucson, AZ, USA
          [10 ]Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA
          [11 ]Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, USA
          Author notes
          [# ]Corresponding authors: David A. Ahlquist, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, Phone: 507-266-4338, Fax: 507-266-0350, ahlquist.david@ 123456mayo.edu , Nicholas Chia, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, Phone: 507-538-0614, Fax: 507-284-1876, chia.nicholas@ 123456mayo.edu
          [*]

          Co-first authors

          Article
          PMC5225053 PMC5225053 5225053 nihpa817922
          10.1158/1055-9965.EPI-16-0337
          5225053
          27672054
          b7ecde62-ef56-468c-bed7-193c959c0091
          History
          Categories
          Article

          colorectal cancer,gut microbiota,adenoma,bile acids,H2S
          colorectal cancer, gut microbiota, adenoma, bile acids, H2S

          Comments

          Comment on this article